BioTelemetry, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 23 rows in 2021. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2021-02-09: Reporting owner Getz Heather C; Form 4; Security Stock Options (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2021-02-09: Reporting owner Getz Heather C; Form 4; Security Stock Options (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2021-02-09: Reporting owner Getz Heather C; Form 4; Security Stock Options (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2021-02-09: Reporting owner Getz Heather C; Form 4; Security Stock Options (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2021-02-09 | Getz Heather C Officer (EVP, CFO & CAO) | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −23,578 0 owned after | $63.32 | 2021-02-11 | |
| 2021-02-09 | Getz Heather C Officer (EVP, CFO & CAO) | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −29,040 0 owned after | $61.64 | 2021-02-11 | |
| 2021-02-09 | Getz Heather C Officer (EVP, CFO & CAO) | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −22,455 0 owned after | $62.43 | 2021-02-11 | |
| 2021-02-09 | Getz Heather C Officer (EVP, CFO & CAO) | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,675 0 owned after | $47.35 | 2021-02-11 | |
| 2021-02-09 | Getz Heather C Officer (EVP, CFO & CAO) | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −18,991 0 owned after | $38.65 | 2021-02-11 | |
| 2021-02-09 | Getz Heather C Officer (EVP, CFO & CAO) | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,634 0 owned after | $18.78 | 2021-02-11 | |
| 2021-02-09 | Stoica Andrei G Officer (SVP & CTO) | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −50,000 0 owned after | $32.27 | 2021-02-11 | |
| 2021-02-09 | Broadway Fred Officer (President BioTel Heart) | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −12,058 0 owned after | $63.32 | 2021-02-11 | |
| 2021-02-09 | Broadway Fred Officer (President BioTel Heart) | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −15,558 0 owned after | $61.64 | 2021-02-11 | |
| 2021-02-09 | Broadway Fred Officer (President BioTel Heart) | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −15,158 0 owned after | $62.43 | 2021-02-11 | |
| 2021-02-09 | Broadway Fred Officer (President BioTel Heart) | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,003 0 owned after | $47.35 | 2021-02-11 | |
| 2021-02-09 | Broadway Fred Officer (President BioTel Heart) | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,653 0 owned after | $38.65 | 2021-02-11 | |
| 2021-02-09 | Broadway Fred Officer (President BioTel Heart) | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −9,369 0 owned after | $18.78 | 2021-02-11 | |
| 2021-02-09 | Wadhwa Manish Officer (SVP & CMO) | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,176 0 owned after | $18.78 | 2021-02-11 | |
| 2021-02-09 | Capper Joseph H Director, Officer (President & CEO) | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −54,235 0 owned after | $67.33 | 2021-02-11 | |
| 2021-02-09 | Capper Joseph H Director, Officer (President & CEO) | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −313,232 0 owned after | $69.20 | 2021-02-11 | |
| 2021-02-09 | Capper Joseph H Director, Officer (President & CEO) | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −257,177 0 owned after | $69.46 | 2021-02-11 | |
| 2021-02-09 | Capper Joseph H Director, Officer (President & CEO) | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −104,468 0 owned after | $63.32 | 2021-02-11 | |
| 2021-02-09 | Capper Joseph H Director, Officer (President & CEO) | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −122,538 0 owned after | $61.64 | 2021-02-11 | |
| 2021-02-09 | Capper Joseph H Director, Officer (President & CEO) | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −94,752 0 owned after | $62.43 | 2021-02-11 | |
| 2021-02-09 | Capper Joseph H Director, Officer (President & CEO) | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −45,917 0 owned after | $47.35 | 2021-02-11 | |
| 2021-02-09 | Capper Joseph H Director, Officer (President & CEO) | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −49,604 0 owned after | $38.65 | 2021-02-11 | |
| 2021-02-09 | Capper Joseph H Director, Officer (President & CEO) | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −42,291 0 owned after | $18.78 | 2021-02-11 |